These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2412022)

  • 1. Inhibition of the renin-angiotensin system in the treatment of heart failure: why, when, and where.
    Nicholls MG
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S98-102. PubMed ID: 2412022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refocus on diuretics in the treatment of heart failure.
    Taylor SH
    Eur Heart J; 1995 Jul; 16 Suppl F():7-15. PubMed ID: 8521885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating patients with severe heart failure.
    Eichhorn EJ
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):24-31. PubMed ID: 19667605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug suppression of the angiotensin system in congestive heart failure.
    Sullivan JM
    Annu Rev Med; 1983; 34():169-77. PubMed ID: 6190432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conversion enzyme inhibitors in the treatment of chronic congestive cardiac failure. Physiopathologic bases of their use].
    Garabedian VG
    Presse Med; 1985 Dec; 14(44):2264-7. PubMed ID: 3003732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.
    Richer C; Gervais M; Fornes P; Giudicelli JF
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):772-81. PubMed ID: 10598119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored therapy to hemodynamic goals for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 1999 Aug; 1(3):251-7. PubMed ID: 10935671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.